King Pharmaceuticals obtained about twenty smaller branded drugs from the start up of the company to 1998 when went public in June 1998.

After Mylan had announced a deal to acquire King Pharmaceuticals.

He recommends that investors gradually put some money into growth areas such as health care; among his favorites are Amgen and King Pharmaceuticals.

Another caution light is blinking at King Pharmaceuticals, a maker of prescription drugs.

Then two of the manufacturers, King Pharmaceuticals and American Home Products, stopped making the vaccine after federal inspectors found problems with their manufacturing processes.

King Pharmaceuticals said last month that it would no longer make the vaccine.

Two years earlier, King Pharmaceuticals ended its program.

A spokesman for King Pharmaceuticals did not return phone calls.

Another drug in the class is Sonata, marketed by King Pharmaceuticals.

Elan will seek new buyers for two drugs that it agreed to sell to King Pharmaceuticals if litigation significantly delays the transaction.